These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1448131)
21. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program. Shotsky WJ; Cooper JG; Klein SJ Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507 [No Abstract] [Full Text] [Related]
22. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. Vlahov D J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):71-2. PubMed ID: 7648287 [No Abstract] [Full Text] [Related]
23. [The HIV-epidemic among drug addicts in Norway]. Aavitsland P; Nilsen O; Lystad A Tidsskr Nor Laegeforen; 1996 Nov; 116(29):3502-5. PubMed ID: 9019859 [TBL] [Abstract][Full Text] [Related]
24. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Foss AM; Watts CH; Vickerman P; Azim T; Guinness L; Ahmed M; Rodericks A; Jana S Addiction; 2007 Jan; 102(1):114-25. PubMed ID: 17207129 [TBL] [Abstract][Full Text] [Related]
25. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. Des Jarlais DC; Braine N; Yi H; Turner C AIDS Educ Prev; 2007 Apr; 19(2):111-23. PubMed ID: 17411414 [TBL] [Abstract][Full Text] [Related]
26. Continued risky injection subsequent to syringe exchange use among injection drug users in New York City. Paone D; Des Jarlais DC; Caloir S; Jose B; Shi Q; Friedman SR AIDS Educ Prev; 1997 Dec; 9(6):505-10. PubMed ID: 9451478 [TBL] [Abstract][Full Text] [Related]
27. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637 [TBL] [Abstract][Full Text] [Related]
28. [Misuse of syringes--clean syringes should limit the harm. Interview by Jesper Berg]. Legêne L; Fich C Sygeplejersken; 1997 Sep; 97(39):10-1. PubMed ID: 9393076 [No Abstract] [Full Text] [Related]
29. Structural impediments to operational syringe-exchange programs. Heimer R; Bluthenthal RN; Singer M; Khoshnood K AIDS Public Policy J; 1996; 11(4):169-84. PubMed ID: 10915251 [No Abstract] [Full Text] [Related]
30. [ESAP. More access to syringes]. Caceres W Sidahora; 2005; ():18-21. PubMed ID: 16634158 [No Abstract] [Full Text] [Related]
31. In eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. Grund JP; Heckathorn DD; Broadhead RS; Anthony DL J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):104-5. PubMed ID: 7648280 [No Abstract] [Full Text] [Related]
32. Syringe exchange schemes: a report and some commentaries. Br J Addict; 1989 Nov; 84(11):1283-90. PubMed ID: 2597805 [No Abstract] [Full Text] [Related]